Rigel Pharmaceuticals
RIGL
#7467
Rank
S$0.41 B
Marketcap
$23.20
Share price
-2.35%
Change (1 day)
33.35%
Change (1 year)

P/S ratio for Rigel Pharmaceuticals (RIGL)

P/S ratio as of April 2025 (TTM): 1.70

According to Rigel Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 92.6. At the end of 2024 the company had a P/S ratio of 1.62.

P/S ratio history for Rigel Pharmaceuticals from 2001 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20241.62-25.05%
20232.160.33%
20222.16-29%
20213.04-44.23%
20205.44-10.2%
20196.06-29.81%
20188.64-93.19%
2017127997.26%
201611.621.66%
20159.50-60.8%
201424.2-30.56%
201334.9-86.14%
2012252112.73%
20111183658.21%
20103.15-99.52%
2009659
200750.7467.34%
20068.93-28.87%
200512.6-87.63%
2004101293.89%
200325.8708.06%
20023.19-72.2%
200111.5

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
101 5,816.63%๐Ÿ‡บ๐Ÿ‡ธ USA
2.48 45.80%๐Ÿ‡บ๐Ÿ‡ธ USA
3.97 133.69%๐Ÿ‡ฌ๐Ÿ‡ง UK
4.81 183.24%๐Ÿ‡บ๐Ÿ‡ธ USA